Poging GOUD - Vrij
Weight-loss drug Ozempic gets nod for India launch
Business Standard
|October 01, 2025
The race for a share of India's growing obesity market is set to intensify with the Central Drugs Standard Control Organisation (CDSCO) giving Danish drugmaker Novo Nordisk approval for its blockbuster diabetes drug Ozempic.
Approval for the injectable semaglutide-based solution was given on September 26, according to the CDSCO's website. While no timeline has been given, people in the know told Business Standard that the drug was expected to be launched soon.
Experts say Ozempic's entry is expected to give a boost to the antiobesity market, estimated to be ₹752 crore. Of this market, semaglutide accounts for ₹426 crore.
Vikrant Shrotriya, managing director, Novo Nordisk India, said with Ozempic's launch, the company would complete its semaglutide portfolio in the country, providing a range of treatments.
Ozempic is a once-a-week injectable GLP-1 (glucagon-like peptide-1) agonist (a drug or a hormone to produce a reaction) used to treat type-II diabetes, and it has found global demand for its benefits in patients with obesity or other weight-management issues.
Dit verhaal komt uit de October 01, 2025-editie van Business Standard.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Business Standard
Business Standard
The army’s battle within
Women may be marching perfectly in parades but they are still denied the opportunity to serve in combat roles in the Indian Army
6 mins
December 16, 2025
Business Standard
DGCA probe panel on flight disruptions visits IndiGo HQ
The four-member panel, set up by Director General of Civil Aviation Faiz Ahmed Kidwai to investigate largescale operational disruptions at domestic carrier IndiGo earlier this month, visited the airline's headquarters on Monday as part of the ongoing probe, sources said.
1 min
December 16, 2025
Business Standard
Market sees fewer wild swings in H2CY25
Indian equity markets have moved from turbulence to relative calm this year.
2 mins
December 16, 2025
Business Standard
₹ hits new low for 3rd straight session
The rupee hit a new low for a third consecutive trading session on Monday, touching an intraday low of 90.80 per dollar, as uncertainty surrounding the India-US trade deal continued to weigh on the domestic currency, dealers said.
1 min
December 16, 2025
Business Standard
Proposed nuclear energy Bill caps operator's liability at ₹3,000 cr
The government on Monday introduced in Parliament a Bill that seeks to finally open up the Indian civil nuclear energy sector to private sector players, except in uranium mining, after amending specific provisions dealing with thorny issues like the supplier's liability and compensation in case of a nuclear accident.
2 mins
December 16, 2025
Business Standard
Film director Rob Reiner, wife found dead; son arrested
Actor who went on to direct classic films
2 mins
December 16, 2025
Business Standard
States may shoulder 40% of rural job plan funding
Slowing MGNREGA demand
5 mins
December 16, 2025
Business Standard
Exports grow fastest in nearly 3.5 years
Shipments to US, China rose sharply in Nov; gold imports shrank
1 mins
December 16, 2025
Business Standard
ICICI Pru AMC IPO booked 2x on Day 2 of bidding
ICICI Prudential AMC's mega initial public offering (IPO) was subscribed around two times on second day of bidding.
1 min
December 16, 2025
Business Standard
India-US framework trade deal soon: Commerce secy
India and the United States (US) are hoping to finalise a framework trade agreement “soon”, Commerce Secretary Rajesh Agrawal said on Monday.
3 mins
December 16, 2025
Listen
Translate
Change font size